Showing results (1381-1390 of 1,878) with videos related to

Sort By:
Pageof 188
Immunotherapy|October 13, 2021
Keeping it real: implications of real-world treatment outcomes for first-line immunotherapy in metastatic non-small-cell lung cancerGrace G Hsu, Eric MacKay, Nicolas Scheuer, et al.
Immunotherapy|April 13, 2022
Assessing PD-L1 status in mRCC treated with first-line immune-based combinations: a meta-analysisAlessandro Rizzo, Veronica Mollica, Matteo Santoni, et al.
Immunotherapy|April 13, 2022
Successful use of secukinumab in two melanoma patients with immune checkpoint inhibitor-induced inflammatory arthropathyVincent T Ma, Christopher D Lao, Leslie A Fecher, et al.
Immunotherapy|July 27, 2022
Pembrolizumab-associated erythema nodosum in the treatment of metastatic melanomaCathal O'Connor, Paula Finnegan, Derek G Power, et al.
Immunotherapy|July 19, 2022
Emerging advances in nanomedicine for breast cancer immunotherapy: opportunities and challengesMohammad Zaki Ahmad, Ali S Alasiri, Mohammed Yahia Alasmary, et al.
Immunotherapy|July 19, 2022
Clinical course of COVID-19 infection in a melanoma patient treated with nivolumab and bempegaldesleukin: a case reportAmalia Anastasopoulou, Aikaterini Gkoufa, Panagiotis Diamantopoulos, et al.
Immunotherapy|July 19, 2022
4-1BB antibody enhances cytotoxic activity of natural killer cells against prostate cancer cells via NKG2D agonist combined with IL-27Zhang Li, Liang Simin, Kang Jian, et al.
Immunotherapy|April 21, 2022
Pathologically complete remission to combination of invariant NK T cells and anti-CD20 antibody in a refractory HIV+ diffuse large B-cell lymphoma patientJing Wang, Renfang Zhang, Xiangqing Ding, et al.
Immunotherapy|September 30, 2010
Therapeutic targeting of respiratory syncytial virus G-proteinLawrence M Kauvar, Jennifer L Harcourt, Lia M Haynes, et al.
Immunotherapy|September 30, 2010
Role of activin in bacterial infections: a potential target for immunointervention?Sandra Ebert, Roland Nau, Uwe Michel
Pageof 188